Life Sciences Collaborations: Key Considerations in the COVID-19 Era

With the healthcare and life sciences sector at the heart of the pandemic, new issues are arising in the already complex world of life sciences collaborations. This document is a high-level guide that outlines a list of issues to consider in executing these types of agreements in the COVID-19 era.
Read More

Healthcare and life sciences are some of the largest and fastest-growing industries in the world, in addition to being the most regulated, with rapidly changing rules and regulations that often conflict from one country to another. Healthcare and life sciences companies face a number of challenges, including trying to understand how these laws impact their market and M&A strategies while contending with rising R&D costs, loss of patent protection of blockbuster drugs, pricing pressures, and competition from generics. Rapid convergence of the healthcare, life sciences and technology sectors requires even more legal expertise given the additional data privacy and intellectual property concerns.

  • Ranked in the Top 10 Law Firms in the world for Life Sciences, Chambers Global
  • Ranked Band 1 for Life Sciences, Chambers Asia Pacific 2014-2018
  • Medical Law Firm of the Year, ALB Southeast Asia Awards 2017
  • Most Innovative Use of Technology for the Pharma MapApp, FT Most Innovative Lawyer Awards, 2015
  • No. 1 Healthcare M&A firm by deal volume for past three years, Thomson Reuters 2017
  • No. 1 Healthcare M&A firm by cross-border deal volume for past five years, Thomson Reuters 2017